Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

Holcombe JH, Zalani S, Arora VK, Mast CJ; Lispro in Adolescents Study Group.

Clin Ther. 2002 Apr;24(4):629-38.

PMID:
12017407
2.

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.

Deeb LC, Holcombe JH, Brunelle R, Zalani S, Brink S, Jenner M, Kitson H, Perlman K, Spencer M.

Pediatrics. 2001 Nov;108(5):1175-9.

PMID:
11694699
3.

Safety of insulin lispro: pooled data from clinical trials.

Glazer NB, Zalani S, Anderson JH Jr, Bastyr EJ 3rd.

Am J Health Syst Pharm. 1999 Mar 15;56(6):542-7.

PMID:
10192689
4.

Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.

Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM, Marrero D, Mathias SD, Patrick D, Zalani S, Anderson J.

Diabetes Care. 1997 Jun;20(6):948-58.

PMID:
9167105
5.
6.

Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Zalani S, Holley-Guthrie E, Kenney S.

Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9194-9.

7.

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.

J Virol. 1996 Aug;70(8):5131-42.

8.
9.

The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Zalani S, Holley-Guthrie EA, Gutsch DE, Kenney SC.

J Virol. 1992 Dec;66(12):7282-92.

10.

Ascorbic acid concentration of human fetal tissues in relation to fetal size and gestational age.

Zalani S, Rajalakshmi R, Parekh LJ.

Br J Nutr. 1989 May;61(3):601-6.

PMID:
2758014
11.

Supplemental Content

Loading ...
Support Center